PPARG and type 2 diabetes mellitus: Besides, earlier studies have demonstrated that administration of PPAR-γ ligands such as thiazolidinediones exert insulin sensitizing and anti-inflammatory effects through action on adipocytes and are thus widely used to treat metabolic-related disorders such as T2DM and atherosclerosis among others25.